Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year […]
Commerce Bank acquired a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 55,138 shares of the specialty pharmaceutical company’s stock, valued at approximately $6,782,000. Commerce Bank owned 0.09% of Jazz […]
AXS Investments LLC purchased a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 1,490 shares of the specialty pharmaceutical company’s stock, valued at approximately $183,000. Several other large investors also […]
Robeco Institutional Asset Management B.V. trimmed its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 37.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 177,818 shares of the specialty pharmaceutical company’s stock after selling 106,234 shares […]
First National Advisers LLC grew its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 31.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,032 shares of the specialty pharmaceutical company’s stock after acquiring an additional 4,120 shares during the quarter. First National […]